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A B S T R A C T
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:
To assess whether interventions designed to improve access to smoking cessation interventions for adults experiencing homelessness and
interventions designed to help adults experiencing homelessness to quit smoking lead to increased engagement and tobacco abstinence.
To also assess whether smoking cessation interventions for adults experiencing homelessness affect substance use and mental health.
B A C K G R O U N D
Description of the condition
Tobacco use is disproportionately concentrated among low-in-
come populations, with rates exceeding that of the general popu-
lation at least two-fold (Jamal 2015). Among low-income popula-
tions, such as people experiencing homelessness, estimated smok-
ing prevalence ranges between 60% and 80% (Baggett 2013). In-
dividuals with severe mental health disorders and/or substance use
disorders who belong to racial/ethnic minority groups, who are
older, or who self-identify as a gender and sexual minority are dis-
proportionately represented in populations experiencing home-
lessness (Culhane 2013; Fazel 2014). The prevalence of mental
health and substance use disorders is high among people expe-
riencing homelessness. A systematic review concluded that the
most common mental health disorders among this population
were drug (range 5% to 54%) and alcohol dependence (range 8%
to 58%), and that the prevalence of psychosis (range 3% to 42%)
was as high as that of depression (range 0% to 59%) (Fazel 2008).
These populations carry a high burden of tobacco use and to-
bacco-related morbidity and mortality (Schroeder 2009). Persons
experiencing homelessness are three to five times more likely to
die prematurely than those who are not homeless (Baggett 2015;
Hwang 2009), and tobacco-related chronic diseases are the leading
causes of morbidity and mortality among those aged 45 and older
(Baggett 2013b). Among younger homeless-experienced adults (<
45 years), the incidence of tobacco-related chronic diseases is three
times higher than the incidence in age-matched non-homeless
adults (Baggett 2013b).
Persons experiencing homelessness have distinctive tobacco use be-
haviors associated with low income, substance use comorbidities,
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and housing instability that affect their likelihood of successfully
quitting. Epidemiological studies of tobacco use among this pop-
ulation have shown that most adults experiencing homelessness
initiate smoking before the age of 16 (Arnsten 2004). Average daily
cigarette consumption is between 10 and 13 cigarettes per day, and
more than one-third smoke their first cigarette within 30 minutes
of waking (Okuyemi 2006; Vijayaraghavan 2015; Vijayaraghavan
2017). People experiencing homelessness have high rates of con-
current use of alternative tobacco products such as little cigars,
smokeless tobacco, and e-cigarettes (Baggett 2016; Neisler 2018).
They also engage in high-risk smoking practices including ex-
posure compensation when reducing cigarettes smoked per day
and smoking cigarette butts (Garner 2013; Vijayaraghavan 2018).
Smoking norms include sharing or “bumming” cigarettes, and
these practices may reduce the effects of policy interventions such
as increased taxes (Garner 2013; Vijayaraghavan 2018). Individu-
als experiencing homelessness face significant barriers to cessation,
including disproportionately high rates of post-traumatic stress
disorder (PTSD), which can lead to positive associations with
smoking (Baggett 2016a). Smoking cessation is challenging for
people who have to navigate the stressors of homelessness (Baggett
2018; Chen 2016), high levels of nicotine dependence, and lim-
ited access to smoking cessation treatment and smoke-free living
environments (Vijayaraghavan 2016; Vijayaraghavan 2016b). In-
tegrating tobacco dependence treatment into existing services for
homeless-experienced adults remains challenging (Vijayaraghavan
2016b). Staff members may not support quit attempts (Apollonio
2005;Garner 2013), and homeless-experienced adults do not have
consistent access to services or information technologies used to
improve access to cessation interventions (McInnes 2013).
Despite these challenges, over 40% of adults experiencing home-
lessness report making a quit attempt in the past year (Baggett
2013c; Connor 2002). A majority relapse to smoking, with esti-
mates of the quit ratio (i.e. the ratio of former-to-ever smokers)
between 9% and 13% compared to 50% in the general population
(Baggett 2013c; Vijayaraghavan 2016).
Homeless populations have been historically neglected in popula-
tion-wide tobacco control efforts; however, there has been increas-
ing interest in studying the correlates of tobacco use and cessation
behaviors for these populations and in discovering how these in-
dividuals may differ from the general population (Goldade 2011;
Okuyemi 2013). Typically high levels of nicotine dependence
among adults experiencing homelessness are associated with low
likelihood of quitting (Vijayaraghavan 2014). Proximity to a shel-
ter during the week after a quit attempt has been associated with
higher risk of relapse, thought to occur because of increased ex-
posure to environmental cues to smoking (Businelle 2014; Reitzel
2011). In contrast, staying in a shelter, as opposed to on the street,
has been associated with quitting smoking (Vijayaraghavan 2016),
possibly due to exposure to shelter-based smoke-free policies. Stud-
ies have shown that engaging in smoking cessation does not ad-
versely affect substance use behaviors (Apollonio 2016), andhas in-
creased the number of days abstinent from alcohol (Reitzel 2014).
More recent research efforts such as have focused on designing in-
terventions to reduce smoking initiation among youth experienc-
ing homelessness (Shadel 2014), and to improve quit rates among
adults experiencing homelessness (Baggett 2017; Carpenter 2015;
Ojo-Fati 2015; Okuyemia 2006b; Okuyemi 2013; Rash 2018).
Description of the intervention
Interventions designed to support people to stop smoking can
work to motivate people to attempt to stop smoking (“cessation
induction”), or to support people who have already decided to stop
to achieve abstinence (“aid to cessation”). In this review, wewill in-
clude both types of interventions. Many people who are homeless
face barriers to using regular services, such as healthcare services,
through which cessation support is available. The availability of
support to assist a quit attempt can itself create motivation to quit
(Aveyard 2012). Thus one possible intervention to support people
experiencing homelessness is to provide bespoke cessation services
that can operate both tomake quitting seemmore desirable and to
provide treatment for those who are attempting to stop smoking.
The combination of behavioral counseling and pharmacotherapy
(nicotine replacement therapy [NRT], bupropion, or varenicline)
is the gold standard for individually tailored smoking cessation
treatment in the general population (Stead 2016). However, a vast
majority of quit attempts made by people experiencing homeless-
ness are unassisted (Vijayaraghavan 2016). Preference for cessa-
tion aids may vary by cigarette consumption, with light smokers
(0 to 10 cigarettes per day) preferring counseling over medication,
in contrast to moderate/heavy smokers (> 10 cigarettes per day)
(Nguyen 2015).
How the intervention might work
Cessation induction interventions directed at smokers who are not
ready to quit rely on pharmacological, behavioral, or combination
interventions to increase motivation and intention to quit, with
an eventual goal of abstinence. Interventions may include nicotine
therapy sampling to induce practice quit attempts, as described in
Carpenter 2011, or motivational interviewing to induce cessation-
related behaviors among smokers who are not motivated to quit,
as examined in Catley 2016.
Tobacco dependence treatment can provide motivation and sup-
port for change through pharmacotherapy (Cahill 2013), coun-
seling (Lancaster 2017), financial incentives (Notley 2019), or a
combination of these (Stead 2016). Pharmacotherapy can reduce
the urge to smoke and can decrease nicotine withdrawal symp-
toms via NRT, varenicline, or bupropion (Cahill 2013); counsel-
ing can provide support and motivation to make and continue
with quit attempts (Lancaster 2017). For individuals with severe
tobacco dependence, such as people experiencing homelessness,
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multi-component interventions that include behavioral counsel-
ing, combination pharmacotherapy, and other adjunctive meth-
ods such as financial incentives - as discussed in Businelle 2014b,
Baggett 2017, and Rash 2018 - or mobile support - as offered in
Carpenter 2015 - may be beneficial. However, as many quit at-
tempts are unassisted, more may need to be done to remove bar-
riers and facilitate access to cessation support for smokers who are
homeless.
Why it is important to do this review
People experiencing homelessness have unique tobacco use char-
acteristics, including higher likelihood of irregular smoking pat-
terns, reduced exposure to clean indoor air policies, and reliance
on “used” cigarettes (Baggett 2016; Garner 2013; Vijayaraghavan
2018). They receive limited support for cessation from service
providers (Apollonio 2005; Garner 2013). Many countries have
identifiedhomeless-experienced adults as a high-risk group in need
of targeted interventions (Fazel 2014). Tobacco use is the single
most preventable cause of mortality among adults experiencing
homelessness (Baggett 2015). Past efforts to promote tobacco ces-
sation among this population have yieldedmixed results that make
it difficult to assess which types of tobacco dependence treatments
promote abstinence. Our findings will synthesize evidence to date
and will identify interventions that increase quit attempts and ab-
stinence, as well as improve access to treatment, for this vulnerable
population. We will also explore whether cessation interventions
affect mental health or substance use outcomes among this popu-
lation.
O B J E C T I V E S
To assess whether interventions designed to improve access to
smoking cessation interventions for adults experiencing homeless-
ness and interventions designed to help adults experiencing home-
lessness to quit smoking lead to increased engagement and to-
bacco abstinence. To also assess whether smoking cessation inter-
ventions for adults experiencing homelessness affect substance use
and mental health.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We will include randomized controlled trials (RCTs) and cluster
RCTs, with no exclusions based on language of publication or
publication status.
Types of participants
Participants will include homeless and unstably housed adults (>
18 years of age). This will be defined by criteria specified by in-
dividual studies; however we envisage that participants will meet
one or more of the following criteria for homelessness (ANHD
2018; Council to Homeless Persons 2018; Fazel 2014).
1. Individuals and families who do not have a fixed, regular,
and adequate night-time residence, including individuals who
live in emergency shelters for homeless individuals and families,
and those who live in places not meant for human habitation.
2. Individuals and families who will imminently lose their
main night-time residence.
3. Unaccompanied young adults and families with children
and young people who meet other definitions of homelessness.
4. Individuals and families who are fleeing or attempting to
flee domestic violence, dating violence, sexual assault, stalking, or
other dangerous or life-threatening conditions that relate to
violence against an individual or family member.
5. Individuals and families who live in transitional shelters or
housing programs.
6. Individuals and families who are temporarily living with
family or friends.
7. Individuals and families who are living in overcrowded
conditions.
Participants must also be tobacco users who may or may not be
motivated to quit.
Types of interventions
We will include in our review any interventions that:
1. focus on increasing motivation to quit, building capacity
(e.g. providing education or training to provide cessation support
to staff working with people who are homeless), or improving
access to tobacco cessation services in clinical and non-clinical
settings for homeless adults;
2. aim to help people making a quit attempt to achieve
abstinence, including but not limited to behavioral support,
tobacco cessation pharmacotherapies, contingency management,
and app-based interventions; or
3. focus on transitions to long-term nicotine use that do not
involve combustible tobacco.
Control groups may receive no intervention or ’usual care’, as
defined by individual studies.
Types of outcome measures
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Primary outcomes
1. Tobacco abstinence (given the paucity of data on long-term
cessation outcomes among people experiencing homelessness, we
will also assess short-term cessation outcomes), assessed at three
time points
i) Short-term abstinence: < three months after quit day
ii) Medium-term abstinence: ≥ three months and < six
months after quit day
iii) Long-term abstinence: ≥ six months after quit day
We will conduct separate analyses for each time point. We will
use the strictest definition of abstinence used by the study, with
preference for continuous or prolonged (allowing a grace period for
slips) abstinence over point prevalence abstinence. When possible,
we will extract biochemically verified rates (e.g. breath carbon
monoxide, urinary/saliva cotinine) over self-report. We will assess
abstinence on an intention-to-treat basis, using the number of
people randomized as the denominator.
Secondary outcomes
1. Number of participants receiving treatment
2. Number of people making at least one quit attempt as
defined by included studies
3. Abstinence from alcohol and other drugs as defined by self-
reported drug use or through biochemical validation (or both),
at the longest follow-up period reported in the study
4. Point prevalence or continuous estimates (e.g. questionnaire
scores) for mental illnesses (including major depressive disorder,
generalized anxiety disorder, post-traumatic stress disorder,
schizophrenia, and bipolar disorder) as defined by previously
validated survey instruments or physician diagnosis
Search methods for identification of studies
Electronic searches
We will search the Cochrane Tobacco Addiction Group Special-
ized Register, the Cochrane Central Register of Controlled Trials
(CENTRAL), andMEDLINE. TheMEDLINE search strategy is
provided in Appendix 1. The Specialized Register includes reports
of tobacco-related trials identified through research databases, in-
cluding MEDLINE, Embase, and PsycINFO, as well as via trial
registries and handsearching of journals and conference abstracts.
For a detailed account of searches carried out to populate the Reg-
ister, see the Cochrane Tobacco Addiction Group’s website.
Searching other resources
We will search grey literature, including conference abstracts from
the Society for Research on Nicotine and Tobacco. We will con-
tact investigators in the field about potentially unpublished stud-
ies. We will additionally search for registered unpublished trials
through the National Institutes of Health clinical trials registry
(www.clinicaltrials.gov) and the World Health Organization In-
ternational Clinical Trials Registry Platform Search Portal ( http:/
/apps.who.int/trialsearch/).
Data collection and analysis
Selection of studies
Wewill merge search results using reference management software
and will remove duplicate records. Two independent review au-
thors (MV andHS) will examine the titles and abstracts to identify
relevant articles and will subsequently retrieve and examine the
full-text articles to assess adherence with the eligibility criteria. A
third review author (DA) will independently assess whether the
full-text articles meet eligibility criteria. We will exclude all studies
that do not meet inclusion criteria in terms of study design, popu-
lation, or interventions. We will resolve disagreements by discus-
sion, and when necessary, the third review author will arbitrate the
case.
Data extraction and management
Two review authors (MV and HS) will independently extract data
in duplicate. We will contact study authors to obtain missing out-
come data. Once outcome data have been extracted, one of the re-
view authors (MV) will enter them into Review Manager 5.3, and
another (HS) will check them (Higgins 2011). All review authors
(MV, HS, and DA) will extract information from each study for
risk of bias assessments.
We will extract he following information from study reports using
a template developed by DA and modified by MV.
1. Source, including study ID, report ID, reviewer ID,
citation, contact details, and country.
2. Methods, including study design, study objectives, study
site, study duration, blinding, and sequence generation.
3. Participant characteristics, including total number enrolled
and number in each group, setting, eligibility criteria, age, sex,
race/ethnicity, sociodemographics, tobacco use (type,
dependence level, amount used), mental illness, substance use,
other comorbidities, and current residence (unsheltered,
sheltered, single room occupancy hotel or temporary residence,
or supportive housing).
4. Interventions, including total number of intervention
groups and comparisons of interest, specific intervention,
intervention details, and integrity of the intervention.
5. Outcomes, including definition, unit of measurement, and
time points collected and reported.
6. Results, including participants lost to follow-up, summary
data for each group, and subgroup analyses.
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7. Miscellaneous items, including study author conflicts of
interest, funding sources, and correspondence with study
authors.
Assessment of risk of bias in included studies
Two review authors will assess the risk of bias for each included
study, as outlined in the Cochrane Handbook for Systematic Reviews
of Interventions, Chapter 8 (Higgins 2011). Using a risk of bias
table, we will categorize risk of bias as “low risk,” “high risk,” or
“unclear risk” for each domain, with the last category indicating
insufficient information to judge risk of bias. We will assess the
following domains: selection bias (including sequence generation
and allocation concealment), blinding (performance bias and de-
tection bias), attrition bias (incomplete outcome data), and any
other bias. According to guidance from the Cochrane Tobacco
Addiction Group, we will assess performance bias only for studies
of pharmacotherapies, as it is impossible to blind behavioral in-
terventions.
Measures of treatment effect
When possible, we will report a risk ratio (RR) and 95% con-
fidence intervals (CIs) for the primary outcome (i.e. abstinence)
for each included study. The risk ratio is defined as (number of
participants in the intervention group who achieve abstinence/
total number of people randomized to the intervention group)/
(number of participants in the control group who achieve absti-
nence/total number of people randomized to the control group).
We will use an intention-to-treat analysis, in which participants
are analyzed based on the intervention to which they were ran-
domized, irrespective of the intervention they actually received.
For dichotomous secondary outcomes, such as number of people
making a quit attempt and abstinence from substance use, we will
calculate an RR with 95% CI for each study. For any continuous
measures of our mental illness secondary outcome, we will calcu-
late the mean difference (MD) or the standardized mean differ-
ence (SMD), as appropriate for each study.
Unit of analysis issues
The unit of analysis will be the individual. For cluster-randomized
trials, we will assess whether study authors have adjusted for this
clustering, and whether this had an impact on the overall result.
When clustering appears to have had little impact on the results,
we will use unadjusted quit rate data; however when clustering
does appear to have an impact on results, we will adjust for this
using the intraclass correlation (ICC).
Dealing with missing data
When outcome data are missing, we will attempt to contact the
study authors to request missing data. For all outcomes apart from
mental health, we will assume that participants who are lost to
follow-up are continuing smokers, are still using other substances,
did not make a quit attempt, or did not receive treatment. We
will report deaths separately and will not include participants who
have died during the analysis. For the mental health outcome, we
will conduct a complete case analysis.
Assessment of heterogeneity
Wewill classify heterogeneity as clinical, methodological, or statis-
tical (Higgins 2011).We will not attempt ameta-analysis if we ob-
serve significant clinical or methodological heterogeneity between
studies; we will instead report results in a narrative summary. If
we feel it is appropriate to carry out meta-analyses, we will assess
statistical heterogeneity using the I² statistic, which represents the
percentage of the effect that is attributable to heterogeneity versus
chance alone (Chapter 9; Higgins 2011). We will consider an I²
value greater than 50% as evidence of substantial heterogeneity.
Assessment of reporting biases
Wewill assess several forms of reporting bias including outcome re-
porting bias (selective reporting of outcomes), location bias (pub-
lication of research in journals that may have different levels of ac-
cess such as open access publication), and publication bias (publi-
cation or non-publication of studies depending on the direction of
outcome effects), and we will discuss these in our review. We will
assess whether abstinence from tobacco, our primary outcome,
was reported in all included studies, and will report which studies
included this outcome and which did not. If we include more than
10 studies in any analyses, we will generate a funnel plot to help
us assess whether there could be publication bias.
Data synthesis
When meta-analysis is appropriate, we will use the Mantel-
Haenszel random-effects method to calculate pooled, summary,
weighted risk ratios (95%CIs), or inverse-variance random-effects
methods to calculate pooled, summary, weightedMDs (95% CIs)
or SMDs (95% CIs). We will pool separately studies testing inter-
ventions that aim to improve access to smoking cessation interven-
tions and studies that are simply testing the effectiveness of smok-
ing cessation interventions among people experiencing homeless-
ness. Should meta-analyses not be possible, we will provide a nar-
rative assessment of the evidence.
Subgroup analysis and investigation of heterogeneity
When possible, we will conduct subgroup analyses to examine
whether outcomes differ based on:
1. intensity of treatment (e.g. number of counselling sessions);
2. participants’ residential history (sheltered vs unsheltered);
3. participants’ substance use history;
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4. participants’ diagnosis of mental health disorder; and
5. participants’ use of non-cigarette tobacco and nicotine
products.
Sensitivity analysis
Wewill conduct sensitivity analyses by excluding studies with high
risk of bias (judged to be at high risk for one ormore of the domains
assessed).
Summary of findings
We will produce a “Summary of findings” table (Higgins 2011),
presenting the primary outcome (tobacco use abstinence at all time
points), absolute and relativemagnitude of effects, numbers of par-
ticipants, and numbers of studies contributing to these outcomes.
Two independent review authors will also carry out GRADE as-
sessments of the certainty of evidence. Using GRADE criteria
(study limitations, consistency of effect, imprecision, indirectness,
and publication bias), we will grade the quality of evidence as very
low, low, moderate, or high, and will provide footnotes to explain
reasons for downgrading of evidence.
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A P P E N D I C E S
Appendix 1. MEDLINE search strategy
1. (un-housed* OR homeless* OR “unstably housed” OR runaway OR “homeless persons”[mesh] OR housing instability)
2. ((smoking cessation.mp. OR exp Smoking Cessation/) OR “Tobacco-Use-Cessation”/ OR “Tobacco-Use-Disorder”/ OR
Tobacco-Smokeless/ OR exp Tobacco-/ OR ((quit$ or stop$ or ceas$ or giv$) adj5 smoking).ti,ab.)) OR exp Smoking/)
3. ((randomised controlled trial[pt]) OR (controlled clinical trial[pt]) OR (clinical trial[pt])) OR ((pragmatic clinical trial)) NOT
(animals[mh]))
4. 1 AND 2 AND 3
C O N T R I B U T I O N S O F A U T H O R S
The protocol was conceived and prepared by Maya Vijayaraghavan, Holly Elser, and Dorie Apollonio.
D E C L A R A T I O N S O F I N T E R E S T
Maya Vijayaraghavan has no conflicts of interest to report. MV has one pending grant application on the topic of smoke-free policies
in permanent supportive housing for formerly homeless populations.
Holly Elser has no conflicts of interest to report.
Dorie Apollinio has no conflicts of interest to report.
S O U R C E S O F S U P P O R T
Internal sources
• Univeristy of California, San Francisco, San Francisco Cancer Initiative, USA.
External sources
• Tobacco Related Disease Reseach Program, USA.
Grant
9Interventions to reduce tobacco use in people experiencing homelessness (Protocol)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
